Work Area: Competition & Antitrust

Carrefour buys Brazilian assets for US$1.4 billion

Sullivan & Cromwell LLP in New York and Brazilian law firms Machado Meyer Advogados and BMA - Barbosa, Müssnich, Aragão have helped the local branch of French supermarket chain Carrefour acquire Grupo BIG from US counterpart Walmart and private equity investor Advent in a deal worth 7.5 billion reais (US$1.4 billion).

29 March 2021

Nicaragua enacts Central America’s first leniency programme

Nicaragua’s antitrust watchdog has established a new leniency programme for businesses that violate national competition rules, becoming the first country to do so in Central America.

24 March 2021

Mexico conducts largest-ever cartel probe

Mexico's competition enforcer has accused 56 liquefied petroleum (LP) gas suppliers and 34 individuals of sharing markets and colluding on prices, in what it says is its largest-ever investigation.

23 March 2021

Brazil imposes interim measures on food delivery app

Brazil’s antitrust watchdog has imposed interim measures on a leading domestic food delivery application to stop it including exclusivity clauses in its contracts with partner restaurants, marking the first time the agency has issued such an order against a digital platform.

15 March 2021

Colombia shuts down mining cartel

Colombia’s state-owned oil producer has escaped sanctions after the country’s competition authority found no evidence it promoted a cartel in the mining sector that resulted in fines for nine companies, eight of their executives and a trade association.

11 March 2021

Mexican enforcer opposes “unjustified” energy reform bill

Mexico’s antitrust watchdog is calling on the country’s lawmakers to shoot down a bill aimed at strengthening the state-owned electricity utility, claiming the proposed law would grant the company unjustified competitive advantages.

22 February 2021

Brazil conditionally clears Takeda drug portfolio purchase

Brazil’s competition authority has greenlit local drugmaker Hypera Pharma’s bid to purchase a portfolio of medications from Takeda Pharmaceutical after the company offered a “fix-it-first” structural remedy.

26 January 2021

Get unlimited access to all Latin Lawyer content